Abstract
Mesoporous silica nanoparticles (MSNs) have emerged as promising drug carriers. Here we highlight some recent developments related to cell-specific targeting and delivery using MSNs. Some key requirements for carrier design are discussed from a biological perspective, including a suggested experimental work-flow for the evaluation of active cell-specific targeting of nanoparticles. © 2010 The Royal Society of Chemistry.
| Original language | English |
|---|---|
| Pages (from-to) | 2707-2713 |
| Journal | Journal of Materials Chemistry |
| Volume | 20 |
| Issue number | 14 |
| DOIs | |
| Publication status | Published - 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Cancer-cell targeting and cell-specific delivery by mesoporous silica nanoparticles'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver